BERNSTEIN HAROLD (President, R&D & CMO) sold 14.61K shares of MAZE THERAPEUTICS, INC. on the open market
Open‑market sale worth $436.9K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 7/2/2026ACC: 0002050172-26-000025
Officer· President, R&D & CMO
Since Mar 2026
-14.61K
Net shares
Net seller
$436.9K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
14.61K acquired · 29.22K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+14.61K
Price / share
$10.42
Trade value
$152.23K
% of position
New position
7/1/2026
0.00→14.61K
Common Stock
Direct
Shares
−13.41K
Price / share
$29.86
Trade value
$400.46K
% of position
91.8%
7/1/2026
14.61K→1.20K
Common Stock
Direct
Shares
−1.20K
Price / share
$30.34
Trade value
$36.40K
% of position
New position
7/1/2026
1.20K→0.00
Total
Net shares
+0.00
Net value
-$284.64K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/1/2026 | M · Option Exercise | +14.61K | $10.42 | $152.23K | New position | 0.00 | 14.61K |
| Common Stock Direct | 7/1/2026 | S · Sale | −13.41K | $29.86 | $400.46K | 91.8% | 14.61K | 1.20K |
| Common Stock Direct | 7/1/2026 | S · Sale | −1.20K | $30.34 | $36.40K | New position | 1.20K | 0.00 |
| Total | +0.00 | -$284.64K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
14.61K shares
Shares
−14.61K
Strike price
10.42
Held after
192.94K
Exercisable
—
7/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock14.61K shares | 7/1/2026 | M · Option Exercise | −14.61K | 10.42 | — | 192.94K |